期刊文献+

补肾益精法对硬皮病成纤维细胞表型的影响及其表观遗传学意义 被引量:12

Effects of Yin-Nourishing and Marrow-Replenishing Therapy on Scleroderma Fibroblast Phenotype and Its Epigenetic Significance
原文传递
导出
摘要 目的:研究补肾益精法对硬皮病成纤维细胞表型的影响。方法:体外培养建立硬皮病成纤维细胞系,制作补肾益精法含药血清干预硬皮病成纤维细胞,使用实时定量RT-PCR技术,检测胶原表达相关因子及甲基化相关基因的表达情况,比较补肾益精法与5-氮杂-2-脱氧胞苷对硬皮病成纤维细胞的作用。结果:补肾益精法可抑制硬皮病成纤维细胞Ⅰ型胶原α_2(Col1α_2)、转化生长因子β(TGF-β)基因的表达,与5-氮杂-2-脱氧胞苷均可提高胶原抑制因子F1i1与Smad7的表达,补肾益精法可减少DNA甲基转移酶1的表达。结论:补肾益精法可改善硬皮病成纤维细胞促纤维化的表型,其过程可能有表观遗传调控机制参与。 Objective: To study the effects of yin-nourishing and marrow-replenishing therapy on scleroderma fibroblast phenotype. Methods: The scleroderma fibroblast cell lines were established in vitro, and were intervened with the medicated serum containing Chinese medicine which has the actions of nourishing yin and replenishing marrow. The expression of related collagen and methylation genes was detected by real-time quantitative PCR. And the effects of yin-nourishing and marrow-replenishing therapy on scleroderma fibroblasts were compared with those of 5-aza-2-deoxycytidine. Results: Yin-nourishing and marrow-replenishing therapy decreased the expression of Col1 α 2 and TGF- β mRNA, DNA methyltransferase 1, and had similar effects on the expression of Flil and Smad7 compared with 5-aza-2-deoxycytidine. Conclusion: Yin-nourishing and marrow-replenishing therapy can counteract the fibrotic processes in the scleroderma fibroblasts, with possible involvement of epigenetic mechanisms.
出处 《新中医》 CAS 北大核心 2011年第2期134-136,共3页 New Chinese Medicine
基金 广东省自然科学基金项目(编号:10451040701005294) 广东省科学技术厅项目(编号:2010B031600050)
关键词 硬皮病 中医疗法 补肾益精法 成纤维细胞 Scleroderma TCM Therapy Nourishing-Yin and Replenishing-MarrowTherapy Fibroblasts
  • 相关文献

参考文献6

二级参考文献27

  • 1Qi Q, Guo Q, Tan G, et al. Predictors of the scleroderma phenotype in fibroblasts from systemic sclerosis patients [ J ]. J Eur Acad Dermatol Venereol, 2009,23 (2) : 160 - 168. 被引量:1
  • 2Varga J, Abraham D. Systemic sclerosis: a prototypic muhisystem fibrotic disorder [ J ]. J Clin Invest, 2007, 117(3) :557 -567. 被引量:1
  • 3Strickland FM, Richardson BC. Epigenetics in autoimmunity- DNA methylation in systemic lupus erythematosus and beyond[J]. Autoimmunity, 2008,41 (4) :278 - 286. 被引量:1
  • 4Wang Y, Fan PS, Kahaleh B. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts [ J]. Arthritis Rheum, 2006,54 ( 7 ) : 2271 - 2279. 被引量:1
  • 5Klose R J, Bird AP. Genomic DNA methylation: the mark and its mediators [ J ]. Trends Biochem Sci, 2006, 31(2) :89 -97. 被引量:1
  • 6Sapadin AN, Fleischmajer R. Treatment of scleroderma [J]. Arch Dermatol, 2002,138( 1 ) :99 - 105. 被引量:1
  • 7Christman JK. 5 - Azacytidine and 5 - aza - 2' - deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy[J]. Oncogene, 2002,21 ( 35 ) :5483 - 5495. 被引量:1
  • 8Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell, 2007, 128(4): 635-638. 被引量:1
  • 9Bird A. Perceptions of epigenetics. Nature, 2007, 447(7143 ): 396-398. 被引量:1
  • 10Reik W. Stability and flexibility of epigenetie gene regulation in mammalian development. Nature, 2007, 447(7143 ): 425-432. 被引量:1

共引文献42

同被引文献168

引证文献12

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部